Recent developments in ophthalmological medicine have been surging ahead, to the point that IPS cell regenerative medicine is now the cutting edge of recovery and rehabilitation. Those developments require higher accuracy in ophthalmic testing.

Tomey has been part of the overseas market landscape from an early stage, and has established successful relationships with Key Opinion Leaders and Doctors as a leader in ophthalmic diagnostic instruments. This involvement has brought about the innovative development of the anterior OCT, and allowed Tomey to introduce a range of distinctive products to the international market place. Tomey products are utilized not only domestically but also exported globally including markets in Asia, Oceania, North America, Central and South America, Europe, Russia, CIS, Middle East and Africa. We firmly believe Tomey has much to contribute to the development of ophthalmic medicine by providing highly accurate diagnostic instruments worldwide.

Because the heart of Tomey production is centered in Nagoya, we feel the effects of top quality development inherent in the DNA of this traditional manufacturing area, which greatly benefits our customers.